Please find attached letter regarding outcome of Board Meeting held on Friday, 18th September, 2026

Date: 18/09/2026 BSE Limited Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai – 400 001 Scrip Code: 514330/Scrip ID: ONEGLOBAL Subject: Outcome of Board Meeting held on Friday, 18th September, 2026 Ref: Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“SEBI LODR Regulations”) Dear Sir/Madam, In reference to the captioned subject and in continuation of our intimation dated 3rd September, 2026, and Pursuant to Regulation 30, and other applicable provisions of SEBI LODR Regulations, we wish to inform you that the Board of Directors of the Company, at its meeting held today, i.e., Friday, 18th September, 2026, have inter-alia, considered and approved the following(s): 1. Revised Issue Size and Pricing of the Preferential Issue of Equity Shares for consideration other than Cash: The Company proposes to issue, offer and allot 7,06,068 (Seven Lakh Six Thousand Sixty-Eight Only) fully paid-up equity shares of the Company on a preferential basis, having a face value of Rs. 10/- each, at an issue price of Rs. 560.13 (Rupees Five Hundred Sixty Rupees and Thirteen Paise Only) per equity share (including a premium of Rs. 550.13 (Rupees Five Hundred Fifty and Thirteen Paise Only) per share, to Mr. Suresh and Ms. Nithya S in the case of Matrix Labs Diagnocare Private Limited (“MLDPL”) and at an issue price of Rs. 558.99 (Rupees Five Hundred Fifty-Eight and Ninety-Nine Paise Only), (including a premium of Rs. 548.99 (Rupees Five Hundred Forty- Eight and Ninety -Nine Paise Only) per share to Mr. Suresh in the case of Matrix Labs Private Limited (“MLPL”). The aforesaid issue of equity shares is proposed to be made towards discharge of the non-cash consideration payable by the Company for the acquisition of 13,293 (Thirteen Thousand Two Hundred Ninety-Three) equity shares in case of MLDPL, representing 51% of the total issued, subscribed and paid-up equity share capital of MLDPL, and 2,550 (Two Thousand Five Hundred Fifty) equity shares in case of MLPL, representing 51% of the total issued, subscribed and paid-up equity share capital of MLPL (collectively, the “Purchase Shares”). Pursuant to the above, the Company has been advised by BSE Limited (“BSE”) to revise the issue price of the equity shares proposed to be issued on a preferential basis by applying the appropriate pricing methodology in accordance with Chapter V of the SEBI (ICDR) Regulations. Consequent to the revision in the issue price, the number of equity shares proposed to be issued and allotted by the Company has been revised accordingly, while there is no change in the non – cash consideration of Rs. 35,97,81,800/- in respect of MLDPL and Rs. 3,56,35,320/- in respect of MLPL. 2. Addendum to Share Purchase Agreements: In furtherance of the aforesaid intimation and consequent upon the revision in the issue price of the equity shares proposed to be issued on a preferential basis, the Company has entered into the following Addendum to the Share Purchase Agreements (“SPAs”) dated 18th September, 2026, with the respective parties to the original SPAs. ONE GLOBAL SERVICE PROVIDER LIMITED (Formerly known as Overseas Synthetics Limited) CIN : L74110MH1992PLC367633 Telephone : 8657527323 Website : www.1gsp.in E-mail : 1connect@1gsp.in Registered Address : 6th Floor, 601 E Wing, Trade Link Building, B & C Block, Senapati Bapat Marg, Kamla Mill Compound, Lower Parel (W) Mumbai 400013 a) Matrix Labs Diagnocare Private Limited (“MLDPL”): The Company has entered into an Addendum to the SPA with Mr. Suresh, Ms. Nithya S and Matrix Labs Diagnocare Private Limited pursuant to which the terms of the original Share Purchase Agreement have been amended to reflect the revised issue pricing and corresponding revision in number of equity shares of the Company proposed to be issued and allotted to the Sellers towards discharge of the non-cash consideration payable by the Company for acquisition of 13,293 (Thirteen Thousand Two Hundred Ninety-Three) equity shares of MLDPL, representing 51% of the total issued, subscribed and paid-up equity share capital of MLDPL. The aggregate non – cash consideration payable by the Company for the acquisition of the aforesaid equity shares of MLDPL remains unchanged at Rs. 35,97,81,800/- (Rupees Thirty- Five Crore Ninety-Seven Lakh Eighty-One Thousand Eight Hundred only). b) Matrix Labs Private Limited (“MLPL”): The Company has entered into an Addendum to the Share Purchase Agreement with Mr. Suresh and Matrix Labs Private Limited, pursuant to which the terms of the original Share Purchase Agreement have been amended to reflect the revised pricing and corresponding revision in number of equity shares of the Company proposed to be issued and allotted to the Seller towards discharge of the non-cash consideration payable by the Company for acquisition of 2,550 (Two Thousand Five Hundred Fifty) equity shares of MLPL, representing 51% of the total issued, subscribed and paid-up equity share capital of MLPL. The aggregate non- cash consideration payable by the Company for the acquisition of the aforesaid equity shares of MLPL remains unchanged at Rs. 3,56,35,320/- (Rupees Three Crore Fifty-Six Lakh Thirty-Five Thousand Three Hundred Twenty only). Except for the amendments expressly set out in the respective Addendum SPAs, all other terms and conditions of the original Share Purchase Agreements shall remain unchanged and continue to be in full force and effect. Details as required under Regulation 30 read with Part A of Schedule III of the SEBI LODR Regulations, read with SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026 (or the master circular in force on the date of filing), are enclosed herewith as ‘Annexure A1 and A2’ respectively. The Board meeting commenced at 6:00 P.M. and concluded at 8:00 P.M. This is for your information and records. Kindly take the same on record. Thanking you, Yours faithfully, For ONE GLOBAL SERVICE PROVIDER LIMITED (Formerly known as Overseas Synthetics Limited) Sanjay Lalbhadur Upadhaya Managing Director DIN: 07497306 Encl: As above ONE GLOBAL SERVICE PROVIDER LIMITED (Formerly known as Overseas Synthetics Limited) CIN : L74110MH1992PLC367633 Telephone : 8657527323 Website : www.1gsp.in E-mail : 1connect@1gsp.in Registered Address : 6th Floor, 601 E Wing, Trade Link Building, B & C Block, Senapati Bapat Marg, Kamla Mill Compound, Lower Parel (W) Mumbai 400013 ANNEXURE A1 (Pursuant to Regulation 30 read with Part A of Schedule III of the SEBI LODR Regulations, 2015, read with SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026, or the master circular in force on the date of filing) Sr.No. Particulars Details 1. Name(s) of parties with whom Matrix Labs Diagnocare Private Limited (“MLDPL”), Mr. the agreement is entered Suresh, Ms. Nithya S and One Global Service Provider Limited 2. Purpose of entering into the The purpose of entering into the Addendum to the Share agreement Purchase Agreement is to amend and record the revised terms of the proposed acquisition of equity shares of MLDPL by One Global Service Provider Limited, to reflect the revised pricing and corresponding revision in number of equity shares of the Company proposed to be issued and allotted by the Company on a preferential basis, while facilitating the Company's expansion and strengthening of its presence in the diagnostic, pathology and allied healthcare services sector. 3. Size of agreement The aggregate consideration for acquisition of 13,293 equity shares of MLDPL is Rs. 35,97,81,800/- (Rupees Thirty-Five Crore Ninety-Seven Lakh Eighty-One Thousand Eight Hundred only), payable by way of issue and allotment of equity shares of the Company on a preferential basis as non-cash consideration. 4. Shareholding, if any, in the NIL entity with whom the agreement is executed. 5. Significant terms of the The Addendum primarily records the revised terms agreement (in bri [Showing first 8,000 characters — download PDF for full document]